new biomarkers and prognostic indicators in leukemia and mds
Published 9 years ago • 469 plays • Length 10:24Download video MP4
Download video MP3
Similar videos
-
4:28
predicting prognosis in myelodysplastic syndromes
-
6:22
integrated sequencing in aml/mds reveals prognostic constellations
-
1:20:19
biomarker testing and the future of cancer care
-
2:55
prognostic drivers in aml and mds
-
3:42
cll-ipi: a new and improved staging system for cll?
-
2:05
what is a cll biomarker?
-
5:15
high-risk mds/aml: genomic-driven approaches from ash19 - eytan stein, md
-
13:47
myelodysplastic syndrome (mds) - a precursor to acute myeloid leukemia (aml) ?! - hematology series
-
4:26
david sallman: early results of 5f9 in aml and mds
-
6:01
identifying prognostic constellations of driver mutations in acute myeloid leukaemia and myelody...
-
33:19
mds - myeloplastic syndromes - 2023 best of hematology conference
-
34:15
from mds to aml: what every patient needs to know 11/28/17
-
5:17
impact of targeted therapies on treatment of mds and aml
-
1:27
the role of menin inhibitors in the treatment of hr-mds and aml
-
6:53
jacqueline garcia: evaluating venetoclax plus azacitidine in patients with high-risk mds
-
7:43
understanding the recent who mds classification updates
-
4:50
mds & aml: implications of genetic mutations for management
-
2:53
the prognostic impact of idh mutations and the role of idh inhibitors in mds
-
4:32
uma borate: evaluating mbg453 in high-risk mds and aml